About Voy
Voy is one of the largest DTC online healthcare providers in the world. Present in the UK, Germany, Brazil and India. Voy entered India through the 100% acquisition of EarlyFit, which was started in 2025 by two passionate co founders who spent 6 years in New York and witnessed first-hand the power of GLP-1s and how it grew from a niche solution to over 10cr real users worldwide. Earlyfit started as India’s first full-stack tech-led GLP-1 led weight loss platform. At the intersection of healthcare, science, and consumer technology, we combined GLP 1, medical expertise, endocrinologist-led care, diagnostics, nutrition coaching, and ongoing behavioural support into one seamless experience.
About the space
GLP-1s represent a quantum leap in healthcare (think penicillin) and possibly the biggest healthcare opportunity of our lifetimes. The GLP market went from 0 to $60B in just 8 years and estimated to grow to $200B in the next 10. Several multi-billion dollar companies like Voy, Found,
Ro and Hims and Hers have ridden this wave that’s only just arrived in India with the 2025 launch of Mounjaro and Ozempic. We’re 8 years behind the US and Europe (which is super frustrating but also…) means there is a unique chance to category create in a white space (think Paytm for mobile wallets) and in the process, give 10+ years of healthy life to each patient we onboard. Sure, we have some catching up to do but the Indian GLP space has something the West doesn’t - Generics. The patent for semaglutide (Ozempic) in India expired in March 2026 bringing monthly medication prices from Rs 20k a month to Rs 3k a month. With 250 million obese Indians who can now suddenly afford life-changing medical help that’s never existed in the country before, you do the math.
What You’ll Do ?
• Own the sales strategy, revenue targets & growth agenda.
• Build, mentor and energise a high-performing sales team.
• Drive pipeline, forecasting, conversion and market expansion.
• Partner with
📌 Head of Sales (India)
🏢 VOY
📍 India